Xerthra(TM) kits

Xerthra(TM) kits

Products
Xerthra(TM) kits
Xerthra(TM) kits

Information

Xerthra(TM) kits - procedure packs for isolation and separation of platelet rich plasma (PRP) or injectible fibrine (iPRF) from patient's peripheral blood. Xerthra(TM) PRP kit provides a fraction of autologus plasma with increased number of leukocytes which synthesize cytokines and higher amounts of platelets which release several types of growth factors for support tissue regeneration and healing processes. Xerthra(TM) PRP kit guarantees uncomplicated, quick, and precise separation of highly concentrated (up to 9x) 1 to 3 ml of PRP with leukocytes from small amount of peripheral blood (15 ml with anticoagulant). Xerthra(TM) PRP kit is recommended for use in the inflammatory phase of the disease when regenerative action of growth factors as well as regulatory action of leukocytes are required. Xerthra(TM) PRP PURE kit - procedure pack for isolation of platelet-rich plasma with reduced content of leukocytes (LP-PRP) from the patient's peripheral blood. Autologous LP-PRP contains lower number of leukocytes and increased concentration of platelets rich in several growth factors which support healing of the injury over a shorter period of time with less side effects.Xerthra(TM) PRP PURE kit guarantees uncomplicated, precise and convenient isolation of concentrated LP-PRP (1 ml) with reduced number of erythrocytes and leukocytes obtained via double centrifugation of freshly drawn peripheral blood (15 ml with anticoagulant).LP-PRP is recommended for use in chronic, degenerative phase of the disease in which not inflammatory action of leukocytes but the regenerative action of growth factors contained in platelets is essential. Xerthra(TM) iPRF kit - procedure pack for isolation of injectable platelet-rich fibrin (iPRF) from the patient's peripheral blood. In the site of the injection autologous iPRF forms a fibrin network where leukocytes and platelets release cytokines and growth factors over a longer period of time.Xerthra(TM) iPRF kit guarantees isolation fr...
Main Categories
BiopharmaceuticalsFinished Dosage FormsPharmaceutical Packaging
All Categories
BiopharmaceuticalsFinished Dosage FormsMedical Devices and Medical PackagingPharmaceutical PackagingRegenerative Medicine
Distribution areas
OceaniaNorth America (USA, Canada)Middle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied from
Poland
BiovicoBiovico is a biotechnology and pharmaceutical company focused on researching and developing new innovative and rigorously tested products, manufacturing in the highest GMP level quality and providing with comprehensive and holistic solutions to professionals and patients around the world. From inception in 2008 R&D was a clear focus, understanding that the most important and lasting effects can come only through scientific endeavour. Very soon the first HA product Biolevox family was developed and the line continued to grow and expand in terms of indications for use and viability, obtaining a very significant share of the Polish orthopedic market. Further products related to autologous blood derived platelet rich plasma - Xerthra family and multiple others. It has led to progress and development in multiple fields with pharmaceutical, medical devices and biofermentation. 15 years on the market, nearly 50 countries all around the world, over 200 employees, Biovico has finished several clinical studies for unique products and started many others. With Multiple patents to its name, company's fields of expansion and increasing revenues are the staple of good business. Expanding both in terms of reach to new markets and in man-power at R&D, creating new exciting departments offering services including contract manufacturing, increasing production capacity by 500%, creating a logistics center and both organic and non-organic growth in M&A processes. Unique products include Lipotris, Wint, Monoshot, Hyrac, Progum - provide most exciting new solutions.

Log in

See all the content and easy-to-use features by logging in or registering!